#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Astrocytoma malignant Heart disease congenital Osteosarcoma Polycythaemia vera Mitochondrial myopathy Transient ischaemic attack Cluster headache Retinopathy of prematurity Chronic myeloid leukaemia Asthma Endocrine ophthalmopathy Neuropathic arthropathy Infective uveitis Turner's syndrome Oesophageal achalasia More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis Hepatoblastoma – Trials in Disease Idiopathic inflammatory myopathy Propionic acidaemia Retinitis pigmentosa – Life with Disease Propionic acidaemia – Basic Information Friedreich’s ataxia – Treatment Hepatic angiosarcoma – Diagnostics Von Willebrand’s disease – Life with Disease Cystic fibrosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ustekinumab GSKVX000000034797 Anhydrous Cholestyramine VINBLASTINE OMECAMTIV MECARBIL Petosemtamab Vilobelimab Ep0042 Gimeracil Lenacapavir Pegcetacoplan Selinexor Diphenhydramine Hydrochloride Ly4100511 Somatostatin Lecanemab Evencaleucel Regorafenib Resomelagon Lamivudine More therapies…

    Learn about Your Condition

    Iron overload Tumour thrombosis Pulmonary resection Dementia Benign neoplasm of ureter Haemofiltration Congenital ureteric anomaly Gaucher's disease type III Ewing's sarcoma recurrent Asymptomatic HIV infection Craniosynostosis Myelofibrosis Triple positive breast cancer Thalassaemia alpha Dedifferentiated liposarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Croatia

  • Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Petosemtamab
    • Pembrolizumab
    Austria Belgium Croatia Czechia France Germany +8
  • Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

    Not recruiting

    3 1
    Investigated Drugs:
    • Risankizumab
    Belgium Bulgaria Croatia Czechia Denmark Estonia +11
  • Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

    Not recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Obicetrapib
    Bulgaria Croatia Czechia Denmark Finland Germany +7
  • Study of Adagrasib Dosing in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Adagrasib
    Croatia France Greece Hungary Italy The Netherlands +3
  • Study on Ganaxolone for Patients with Refractory Status Epilepticus

    Not recruiting

    3 1
    Investigated Diseases:
    • Status epilepticus
    Investigated Drugs:
    • Ganaxolone
    Austria Belgium Croatia Czechia Denmark Finland +8
Previous Page
1 … 43 44 45

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Upadacitinib Pembrolizumab Vedolizumab Trospium Chloride Xanomeline Tartrate Prednisone Ocrelizumab Semaglutide Rituximab Fluorescein Sodium Tocilizumab Guselkumab Cisplatin Sodium Chloride Risankizumab Lenalidomide Efgartigimod Alfa Paracetamol Methylprednisolone Carboplatin Teriflunomide Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues Bendamustine Hydrochloride Pemetrexed Cyclophosphamide Gemcitabine Lidocaine Hydrochloride Monohydrate Methylprednisolone Sodium Succinate Ruxolitinib Methylprednisolone Acetate Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Abdominal infection Acute coronary syndrome Acute haemorrhagic ulcerative colitis Acute myeloid leukaemia Acute myocardial infarction Age-related macular degeneration Alopecia areata Arteriosclerosis Asthma Atrial fibrillation Axial spondyloarthritis B-cell lymphoma B-cell lymphoma recurrent B-cell lymphoma refractory B-cell type acute leukaemia Bipolar disorder Bipolar I disorder Bladder cancer Breast cancer Breast cancer metastatic Bronchiectasis Cardiac amyloidosis Cardiac failure Cardiac failure chronic Cardiovascular disorder Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic left ventricular failure Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia refractory Chronic obstructive pulmonary disease Chronic spontaneous urticaria Coagulopathy Coeliac disease Colitis ulcerative Constipation Crohn's disease Dementia Alzheimer's type Dementia of the Alzheimer's type with delusions Dermatitis atopic Dermatomyositis Diabetic foot infection Diabetic retinal oedema Diffuse large B-cell lymphoma Dry age-related macular degeneration Epidermolysis bullosa Factor IX deficiency Factor VIII deficiency Familial hypertriglyceridaemia Focal segmental glomerulosclerosis Follicular lymphoma Generalised tonic-clonic seizure Gingival bleeding Haemophilia A with anti factor VIII Haemophilia B with anti factor IX Haemorrhage prophylaxis Hepatic cirrhosis Hepatocellular carcinoma HER2 positive breast cancer Hereditary angioedema Hidradenitis Hodgkin's disease Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hyperlipidaemia Hypertension Hypertriglyceridaemia Hypertrophic cardiomyopathy Idiopathic generalised epilepsy Idiopathic pulmonary fibrosis IgA nephropathy Immune thrombocytopenia Interstitial lung disease Iron deficiency Lupus nephritis Major depression Mania Medullary thyroid cancer Metabolic dysfunction-associated steatohepatitis Metastatic malignant melanoma Multiple sclerosis Multiple sclerosis relapse Myelofibrosis Myeloproliferative neoplasm Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephrogenic anaemia Nephropathy Neurodermatitis Neurogenic bladder Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-small cell lung cancer Non-small cell lung cancer metastatic Noonan syndrome Obesity Osteoarthritis Ovarian cancer Ovarian cancer metastatic Overweight Partial seizures Pemphigoid Plasma cell myeloma Plasma cell myeloma refractory Pneumonia bacterial Polycythaemia vera Pouchitis Primary biliary cholangitis Primary myelofibrosis Primary progressive multiple sclerosis Progressive relapsing multiple sclerosis Psoriatic arthropathy Psychotic disorder Pulmonary arterial hypertension Pyelonephritis Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal cell carcinoma Renal disorder Rheumatoid arthritis Schizophrenia Secondary progressive multiple sclerosis Short stature Sjogren's syndrome Skin squamous cell carcinoma metastatic Skin squamous cell carcinoma recurrent Small for dates baby Spinal muscular atrophy Squamous cell carcinoma of head and neck Status epilepticus Systemic lupus erythematosus Systemic scleroderma Tardive dyskinesia Turner's syndrome Type 2 diabetes mellitus Urinary tract infection

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!